A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections of insulin to their first automated pump improved users’ time in a ...

Juvenile (or Type ... (IDF) Diabetes Atlas 2021. Indian doctors are also recommending homegrown artificial pancreas like ...

Medtronic's MiniMed 670G - the closest ... the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to self-inject basal insulin ...

In the UK, the medical governing body NICE have issued guidance to the NHS outlining those people with type 1 diabetes that may be suitable ... to learn more about insulin pump therapy please visit ...